Extension of Time to File SOU

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 09/30/2011)

---

PTO Form 1581 (Rev 9/2005)

OMB No. 0651-0054 (Exp. 09/30/2011)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: ODACTRA
SERIAL NUMBER: 76635194

The applicant, Merck & Co., Inc., having an address of One Merck Drive P.O. Box 100, Whitehouse Station, New Jersey United States 088890100, requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 05/23/2006.

For International Class 005:
Current identification: Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, gastrointestinal diseases and disorders, cancer, obesity, inflammation and inflammatory diseases, respiratory diseases and disorders, musculoskeletal disorders, osteoporosis, menopausal symptoms and disorders, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations and antiemetic preparations

This filing does NOTcover the following goods or services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods or services are either being permanently deleted or included in a separately filed Request to Divide: gastrointestinal diseases and disorders, antiemetic preparations

The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the following goods or services listed in the Notice of Allowance or as subsequently modified for this specific class: Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, cancer, obesity, inflammation and inflammatory diseases, respiratory diseases and disorders, musculoskeletal disorders, osteoporosis, menopausal symptoms and disorders, anti-infective preparations, anti-viral preparations, immunological preparations, analgesic preparations, ophthalmic preparations

This is the third extension request.   The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by the extension request: product or service research development

The applicant hereby appoints Debra A. Shelinsky Greene and Kevin M. Dugan, Robert Peverada, Susan C. Mattson of  MERCK & CO., INC., PO BOX 100, WHITEHOUSE STATION, New Jersey United States 08889-0100 to submit this Request for Extension of Time to File a Statement of Use on behalf of the applicant.

A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.


Declaration

The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /kmd/      Date Signed: 10/30/2007
Signatory's Name: Kevin M. Dugan
Signatory's Position: Attorney

Mailing Address:
   MERCK & CO., INC.
   
   PO BOX 100
   WHITEHOUSE STATION, New Jersey 08889-0100

Mailing Address:
   MERCK & CO., INC.
   
   PO BOX 100
   WHITEHOUSE STATION, New Jersey 08889-0100

RAM Sale Number: 1998
RAM Accounting Date: 10/31/2007

Serial Number: 76635194
Internet Transmission Date: Tue Oct 30 16:12:00 EDT 2007
TEAS Stamp: USPTO/ESU-XXX.XX.XX.XXX-2007103016120095
8962-76635194-40069e796ad6e851783b357ce5
ba537b1-DA-1998-20071030161010598231